Move Over, Martin ShkreliJune 13, 2019 |
This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs
Quick Read
Patients who experience organ failure need a transplant to improve their odds of survival and to achieve a better quality of life
Quick Read
The War to Free ScienceJune 11, 2019 |
How librarians, pirates, and funders are liberating the world’s academic research from paywalls
Quick Read
Just 50 years ago, some 1,000 small and family-owned seed companies were producing and distributing seeds in the United States; by 2009, there were fewer than 100. Thanks to a series of mergers and acquisitions over the last few years, four multinational agrochemical firms now control over 60 percent of global seed sales
Quick Read
Many patients like Bacon struggle to get insurance coverage for their mental health treatment, even though two federal laws were designed to bring parity between mental and physical health care coverage. Recent studies and a legal case suggest serious disparities remain
Quick Read
As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million
Quick Read
When ‘Right to Try’ Isn’t EnoughMay 31, 2019 |
Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding
Quick Read
Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever
Quick Read